Erectile Dysfunction treatments
Browse treatment options in this category. Independent EU-registered doctors review every assessment, and licensed pharmacy fulfilment is confirmed later in the route where clinically appropriate.
Choose an option to review
Pricing is indicative where shown. Final route, fulfilment, and whether treatment is clinically appropriate remain subject to independent doctor review.
Cialis
Cialis (tadalafil) is a prescription medication used to treat erectile dysfunction (ED) in men. It belongs to a class of drugs called PDE5 inhibitors and works by increasing blood flow to the penis during sexual stimulation. Cialis is known for its long duration of action - up to 36 hours - earning it the nickname "the weekend pill". It is also approved for treating benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension.
Generic Viagra (Sildenafil)
Generic sildenafil contains the same active ingredient as branded Viagra at a lower cost. It has the same effectiveness, safety profile, and mechanism of action as the original medication.
Levitra
Levitra (vardenafil) is a prescription medication for treating erectile dysfunction (ED) in men. It belongs to the PDE5 inhibitor class of drugs and helps achieve and maintain an erection during sexual activity. Levitra typically works faster than some other ED medications and may be effective in men who have not responded well to other treatments. It is taken as needed, approximately 25-60 minutes before sexual activity.
Viagra (Sildenafil Citrate)
Viagra (sildenafil) is the first and most well-known treatment for erectile dysfunction. Originally developed for heart conditions, it revolutionized ED treatment. Effective for 4-6 hours.
Interested in Erectile Dysfunction?
Complete a confidential health assessment reviewed by an independent EU-registered doctor.
Start AssessmentErectile dysfunction treatments in Europe
Erectile dysfunction (ED) — defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance — is one of the most prevalent male health conditions in Europe. Clinical studies estimate that ED affects approximately 19–52% of men between the ages of 40 and 70, with prevalence increasing markedly with age. Despite this, it remains significantly undertreated, with many men not seeking help due to embarrassment or a lack of accessible, confidential services.
ED can have both psychological and physiological causes, and in most cases the two are interrelated. Physiological factors include cardiovascular disease, diabetes, hypertension, hyperlipidaemia, hormonal imbalances, and neurological conditions. Lifestyle factors — including smoking, excessive alcohol consumption, obesity, and physical inactivity — are also established risk factors. Psychological contributors include performance anxiety, relationship difficulties, depression, and stress.
Critically, erectile dysfunction is recognised by European cardiovascular guidelines as a potential early marker of atherosclerosis and future cardiac events. Men presenting with new-onset ED should be evaluated for cardiovascular risk factors by a qualified clinician.
The first-line pharmacological treatment for ED is the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. These medications enhance the natural physiological pathway that produces an erection in response to sexual stimulation — they do not produce erections independently and are not effective without arousal. Four PDE5 inhibitors are currently EMA-approved: sildenafil, tadalafil, vardenafil, and avanafil.
Available treatments
The following EMA-approved prescription medications are available for erectile dysfunction through EU-registered doctors. This comparison is provided for informational purposes only.
| Medication | Active Ingredient | Onset | Duration | Notes |
|---|---|---|---|---|
| Sildenafil | Sildenafil citrate | 30–60 min | 4–6 hours | Generic available; original Viagra |
| Tadalafil | Tadalafil | 30–60 min | Up to 36 hours | Also available as daily 5 mg dose |
| Vardenafil | Vardenafil HCl | 25–60 min | 4–6 hours | Also available as orodispersible tablet |
| Avanafil | Avanafil | 15–30 min | 6–12 hours | Fastest onset; fewer food/alcohol interactions |
Key distinctions:
- Sildenafil: The most widely prescribed PDE5 inhibitor globally. Generic versions are available in most EU countries, making it typically the most cost-accessible option.
- Tadalafil: The longest duration of action, earning it the informal name “the weekend pill.” The daily low-dose formulation (5 mg) allows spontaneous sexual activity without planning around timing.
- Vardenafil: Similar efficacy profile to sildenafil. The orodispersible (dissolving tablet) formulation provides a discreet and convenient alternative to standard tablets.
- Avanafil: The newest approved PDE5 inhibitor. Its faster onset and more selective mechanism may result in fewer side effects in some men, though individual response varies.
How to get erectile dysfunction treatment online
Prescrivia operates as a technology intermediary. We do not prescribe medications, employ doctors, or sell medicines. Our platform connects patients across Europe with independent EU-registered doctors and licensed pharmacies.
The process:
-
Complete a health assessment — Answer a structured set of medical questions covering the nature and duration of your ED, cardiovascular health, diabetes status, current medications (particularly nitrates or alpha-blockers), blood pressure, and lifestyle factors.
-
Independent doctor review — An independent EU-registered doctor reviews your assessment. If a PDE5 inhibitor is clinically appropriate, the doctor may issue a prescription. If contraindications are identified, the doctor will explain and may suggest in-person follow-up.
-
Pharmacy fulfilment — If a prescription is issued, it is passed to a licensed EU pharmacy partner. Medication is dispensed and delivered discreetly to your address.
Important: Prescrivia does not guarantee that a prescription will be issued. Prescribing decisions are made entirely by independent medical professionals.
How we compare
| Through Prescrivia | In-person GP appointment | |
|---|---|---|
| Availability | 24/7 online assessment | Subject to appointment availability |
| Wait time | Assessment reviewed within hours | Days to weeks depending on location |
| Travel required | No | Yes |
| Confidentiality | Full GDPR-compliant data protection | Standard clinical confidentiality |
| Prescribing decision | Made by independent EU-registered doctor | Made by your GP |
| Cost | Transparent pricing displayed upfront | Varies by country and healthcare system |
Note: ED associated with chest pain, severe cardiovascular disease, recent heart attack or stroke, or other complex comorbidities requires in-person specialist evaluation before any pharmacological treatment is considered. Prescrivia’s platform is designed for adults whose ED profile is suitable for remote assessment.
Sources
Medical information on this page is based on the following sources:
- European Medicines Agency (EMA). Viagra/sildenafil — Summary of Product Characteristics. Available at: ema.europa.eu
- Feldman HA, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology. 1994;151(1):54-61.
- Vlachopoulos CV, et al. Erectile dysfunction as a cardiovascular risk factor. European Heart Journal. 2013.
This content is reviewed periodically to reflect updated clinical guidance. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.
Frequently asked questions
- Can I get erectile dysfunction medication online in Europe?
- Yes. Prescrivia connects patients with independent EU-registered doctors who can review your health profile and, where clinically appropriate, issue a prescription for erectile dysfunction medication. The entire process is completed online with full confidentiality.
- What is the difference between sildenafil and tadalafil?
- Both are PDE5 inhibitors that work by the same mechanism, but they differ primarily in duration of action. Sildenafil works for approximately 4–6 hours and is typically taken 30–60 minutes before activity. Tadalafil lasts up to 36 hours and is also available as a once-daily low-dose formulation for spontaneous use.
- Are there newer ED medications beyond sildenafil?
- Yes. Vardenafil and avanafil are also EMA-approved PDE5 inhibitors. Avanafil has a faster onset than sildenafil — effects can begin within 15 minutes for some men. The most appropriate choice depends on individual health factors and preference, which the reviewing doctor will assess.
- Is it safe to take ED medication with other medications?
- PDE5 inhibitors are contraindicated with nitrate medications (commonly used for chest pain and heart conditions), as the combination can cause a dangerous drop in blood pressure. Other drug interactions also exist. This is why a medical assessment is required before any prescription is issued.
- Can erectile dysfunction indicate a more serious health problem?
- ED can be an early warning sign of cardiovascular disease, diabetes, hypertension, or hormonal imbalances. The health assessment includes questions to screen for relevant risk factors. If warranted, the reviewing doctor may recommend further investigation before or alongside treatment.
Start your route
Ready to begin your assessment?
Complete a short health assessment and, where clinically appropriate, connect with an independent EU-registered doctor for review.